Ocugen (OCGN) Profit After Tax (2014 - 2026)
Ocugen (OCGN) reported Profit After Tax of -$19.2 million for Q1 2026, down 24.93% on a YoY basis from -$25.5 million in Q1 2025, and down 8.06% quarter-over-quarter from -$17.7 million in Q4 2025.
Ocugen (OCGN) Profit After Tax (2014 - 2026) Analysis & Trends
Ocugen has reported Profit After Tax for 13 years, with the latest figure at -$19.2 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 24.93% year-over-year to -$19.2 million; the trailing twelve-month figure through Mar 2026 stood at -$71.7 million (down 24.66% YoY), and the FY2025 full-year result was -$67.8 million, down 25.41% from the prior year.
- Profit After Tax for Q1 2026 stood at -$19.2 million, down from -$17.7 million in the prior quarter.
- The five-year high for Profit After Tax was -$11.0 million in Q4 2023, with the low at -$23.9 million in Q3 2022.
- Historically, Profit After Tax has averaged -$17.1 million across 5 years, with a median of -$17.3 million in 2023.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 168.69% — and 2023, when it soared 51.01%.
- Ocugen's Profit After Tax stood at -$22.4 million in 2022, then soared by 51.01% to -$11.0 million in 2023, then declined by 26.95% to -$13.9 million in 2024, then slipped by 27.43% to -$17.7 million in 2025, then dropped by 8.06% to -$19.2 million in 2026.
- The last three Profit After Tax figures came in at -$19.2 million (Q1 2026), -$17.7 million (Q4 2025), and -$20.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -19.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.18 Mn |
| Dec 31, 2025 | -17.75 Mn |
| Sep 30, 2025 | -20.05 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -15.35 Mn |
| Dec 31, 2024 | -13.93 Mn |
| Sep 30, 2024 | -12.97 Mn |
| Jun 30, 2024 | -15.28 Mn |
| Mar 31, 2024 | -11.92 Mn |
| Dec 31, 2023 | -10.97 Mn |
| Sep 30, 2023 | -11.72 Mn |
| Jun 30, 2023 | -23.07 Mn |
| Mar 31, 2023 | -17.33 Mn |
| Dec 31, 2022 | -22.39 Mn |
| Sep 30, 2022 | -23.91 Mn |
| Jun 30, 2022 | -21.48 Mn |
| Mar 31, 2022 | -19.02 Mn |
| Dec 31, 2021 | -14.58 Mn |
| Sep 30, 2021 | -10.76 Mn |
| Jun 30, 2021 | -25.95 Mn |